PIL
0.005
66.7%
IMC
0.038
-36.7%
ERA
0.003
50%
JNS
0.069
-27.4%
TEM
0.007
40%
TSK
0.11
-26.7%
LRM
0.033
37.5%
OVT
0.003
-25%
FBR
0.004
33.3%
PGY
0.004
-20%
PRM
0.004
33.3%
HMI
0.035
-18.6%
QXR
0.004
33.3%
PET
0.014
-17.6%
VEN
0.004
33.3%
AYT
0.005
-16.7%
ALV
0.07
32.1%
IFG
0.01
-16.7%
TRP
0.42
31.3%
T3D
0.04
-16.7%
FCT
0.009
28.6%
CGS
2.09
-16.7%
MOH
0.01
25%
NOR
0.012
-14.3%
RLG
0.005
25%
KOB
0.037
-14%
PVL
0.145
20.8%
RAU
0.22
-13.7%
LMG
0.024
20%
ORN
0.019
-13.6%
VAR
0.006
20%
CPO
0.013
-13.3%
AUA
0.05
19%
VR8
0.021
-12.5%
PGM
0.034
17.2%
WHK
0.007
-12.5%
RGL
0.007
16.7%
RNT
0.045
-11.8%
VRC
0.007
16.7%
ROC
0.15
-11.8%
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

EZZ Life Science (ASX: EZZ): Targets US expansion followingFDA product approvals

Australian genomic life science company EZZ Life Science (ASX: EZZ) has won approval from the United States (US) Food and Drug Administration (FDA) for nine of its products in the food category, presenting a significant US expansion opportunity for EZZ. | ASX announcement: https://announcements.asx.com.au/asxpdf/20240625/pdf/064x2fh3lh72px.pdf